BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Koinuma M, Sano K, Aoyama T, Tanaka E. Association between endotoxemia and histological features of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(4): 712-722 [PMID: 28216979 DOI: 10.3748/wjg.v23.i4.712]
URL: https://www.wjgnet.com/1007-9327/full/v23/i4/712.htm
Number Citing Articles
1
Qian He, Jun Zeng, Kecheng Yao, Wei Wang, Qiong Wu, Renmin Tang, Xuan Xia, Xiulan Zou. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signalingBiochemical and Biophysical Research Communications 2020; 532(3): 362 doi: 10.1016/j.bbrc.2020.08.036
2
Devi Basumatary, Santanu Das, M. Bidyarani Devi, G. Shalini Devi, Pranamika Sarma, Ashis K. Mukherjee, Mojibur R. Khan, Jagat C. Borah. Garcinol enriched fraction of Garcinia morella (Gaertn.) Desr. Fruit rind improves gut health and reduces the risk of nonalcoholic fatty liver disease by regulating PCK1/ACC/SREBP1/FASn pathway in a mouse modelFood Research International 2024; : 115285 doi: 10.1016/j.foodres.2024.115285
3
Yuzhen Wang, Jimin Zheng, Hongtao Hou, Jian Zhang, Shuangfei Qi, Yueqin Li, Nasser Hadal Alotaibi, Khalid Saad Alharbi, Syed Nasir Abbas Bukhari. Effects of berberine on intestinal flora of Non-alcoholic fatty liver induced by High-fat diet through 16S rRNA gene segmentationJournal of King Saud University - Science 2020; 32(5): 2603 doi: 10.1016/j.jksus.2020.04.020
4
Kanav Kaushal, Vipin Gupta, Pooja Goswami, Samagra Agarwal, Sanchit Sharma, Prasenjit Das, Rajni Yadav, Abhinav Anand, Ujjwal Sonika, Deepak Gunjan, Anoop Saraya. Acute Variceal Bleed in Cirrhosis is Associated With Reversible Changes in Tight Junction Protein Expression in the Intestine: A Proof-of-Concept StudyJournal of Clinical and Experimental Hepatology 2022; 12(1): 89 doi: 10.1016/j.jceh.2021.03.009
5
Weifang Huang, Desong Kong. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALDBiomedicine & Pharmacotherapy 2021; 135: 111235 doi: 10.1016/j.biopha.2021.111235
6
Waleska Dornas, Vincent Lagente. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitisPharmacological Research 2019; 141: 418 doi: 10.1016/j.phrs.2019.01.026
7
Seonghwan Hwang, Hwayoung Yun, Sungwon Moon, Ye Eun Cho, Bin Gao. Role of Neutrophils in the Pathogenesis of Nonalcoholic SteatohepatitisFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.751802
8
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Michiharu Komatsu, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosisWorld Journal of Gastroenterology 2018; 24(13): 1440-1450 doi: 10.3748/wjg.v24.i13.1440
9
Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, Tom Houben. Prevention and Treatment of AtherosclerosisHandbook of Experimental Pharmacology 2020; 270: 233 doi: 10.1007/164_2020_352
10
Wei Perng, Jacob E Friedman, Rachel C Janssen, Deborah H Glueck, Dana Dabelea. Endotoxin Biomarkers Are Associated With Adiposity and Cardiometabolic Risk Across 6 Years of Follow-up in YouthThe Journal of Clinical Endocrinology & Metabolism 2022; 107(7): e3018 doi: 10.1210/clinem/dgac149
11
Naoyuki Fujimori, Takeji Umemura, Takefumi Kimura, Naoki Tanaka, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Michiharu Komatsu, Yoko Usami, Kenji Sano, Koji Igarashi, Akihiro Matsumoto, Eiji Tanaka. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2018; 24(11): 1239-1249 doi: 10.3748/wjg.v24.i11.1239
12
Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention StudyJournal of Medicinal Food 2019; 22(7): 729 doi: 10.1089/jmf.2018.0020
13
Naoki Tanaka, Toshifumi Aoyama, Shioko Kimura, Frank J. Gonzalez. Targeting nuclear receptors for the treatment of fatty liver diseasePharmacology & Therapeutics 2017; 179: 142 doi: 10.1016/j.pharmthera.2017.05.011
14
L. Valenti, S. Romeo. Editorial: new insights into the relationship between the intestine and non‐alcoholic fatty liver—is “fatty gut” involved in disease progression?Alimentary Pharmacology & Therapeutics 2017; 46(3): 377 doi: 10.1111/apt.14154
15
Bin Liu, Liping Xiang, Jing Ji, Wei Liu, Ying Chen, Mingfeng Xia, Yuejun Liu, Wenyue Liu, Peiwu Zhu, Yi Jin, Yu Han, Jieli Lu, Xiaoying Li, Minghua Zheng, Yan Lu. Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2Journal of Clinical Investigation 2021; 131(20) doi: 10.1172/JCI144801
16
Josefin Soppert, Elisa Fabiana Brandt, Nicole Maria Heussen, Emona Barzakova, Lars Mathias Blank, Lars Kuepfer, Mathias Walter Hornef, Jonel Trebicka, Joachim Jankowski, Marie-Luise Berres, Heidi Noels. Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2023; 21(11): 2746 doi: 10.1016/j.cgh.2022.11.030
17
Anna Gudan, Dominika Jamioł-Milc, Victoria Hawryłkowicz, Karolina Skonieczna-Żydecka, Ewa Stachowska. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis—A Systematic Review, Meta-Analysis and Meta-RegressionNutrients 2022; 14(24): 5261 doi: 10.3390/nu14245261
18
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E. Feldstein. Triggering and resolution of inflammation in NASHNature Reviews Gastroenterology & Hepatology 2018; 15(6): 349 doi: 10.1038/s41575-018-0009-6
19
Josh Bilson, Jaswinder K. Sethi, Christopher D. Byrne. Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal functionProceedings of the Nutrition Society 2022; 81(2): 146 doi: 10.1017/S0029665121003815
20
Tomasz Kostrzewski, Paloma Maraver, Larissa Ouro‐Gnao, Ana Levi, Sophie Snow, Alina Miedzik, Krista Rombouts, David Hughes. A Microphysiological System for Studying Nonalcoholic SteatohepatitisHepatology Communications 2020; 4(1): 77 doi: 10.1002/hep4.1450
21
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
22
Ye Eun Cho, Yong Seong Kwon, Seonghwan Hwang. Heterogeneous population of macrophages in the development of non-alcoholic fatty liver diseaseLiver Research 2023; 7(1): 16 doi: 10.1016/j.livres.2022.06.001
23
Jessica Latorre, Ramon Díaz-Trelles, Ferran Comas, Aleix Gavaldà-Navarro, Edward Milbank, Nathalia Dragano, Samantha Morón-Ros, Rajesh Mukthavaram, Francisco Ortega, Anna Castells-Nobau, Núria Oliveras-Cañellas, Wifredo Ricart, Priya P. Karmali, Kiyoshi Tachikawa, Pad Chivukula, Francesc Villarroya, Miguel López, Marta Giralt, José Manuel Fernández-Real, José María Moreno-Navarrete. Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulationMolecular Therapy - Nucleic Acids 2022; 29: 599 doi: 10.1016/j.omtn.2022.08.003
24
Teresa Auguet, Laia Bertran, Andrea Barrientos-Riosalido, Blanca Fabregat, Beatriz Villar, Carmen Aguilar, Fàtima Sabench. Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?International Journal of Environmental Research and Public Health 2022; 19(20): 13495 doi: 10.3390/ijerph192013495
25
Guy C. Brown, Marta Camacho, Caroline H. Williams‐Gray. The Endotoxin Hypothesis of Parkinson's DiseaseMovement Disorders 2023; 38(7): 1143 doi: 10.1002/mds.29432
26
Ina Bergheim, José María Moreno‐Navarrete. The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction‐associated steatotic liver diseaseEuropean Journal of Clinical Investigation 2024; 54(7) doi: 10.1111/eci.14224
27
Ayla Coussa, Hayder A. Hasan, Thomas M. Barber. Early Predictors of Gestational Diabetes Mellitus in IVF-Conceived PregnanciesEndocrine Practice 2021; 27(6): 579 doi: 10.1016/j.eprac.2020.10.020
28
Kanav Kaushal, Samagra Agarwal, Sanchit Sharma, Pooja Goswami, Namrata Singh, Vikas Sachdev, Shekhar Poudel, Prasenjit Das, Rajni Yadav, Dinesh Kumar, Gaurav Pandey, Deepak Gunjan, Anoop Saraya. Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept StudyJournal of Clinical and Experimental Hepatology 2022; 12(4): 1102 doi: 10.1016/j.jceh.2022.01.006
29
Anjana Sajeev, Mangala Hegde, Sosmitha Girisa, Thulasidharan Nair Devanarayanan, Mohammed S. Alqahtani, Mohamed Abbas, Samir Kumar Sil, Gautam Sethi, Jen-Tsung Chen, Ajaikumar B. Kunnumakkara. Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic DiseasesBiomolecules 2022; 12(9): 1185 doi: 10.3390/biom12091185
30
Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Kenji Sano, Akira Horiuchi, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Miglitol attenuates non‐alcoholic steatohepatitis in diabetic patientsHepatology Research 2018; 48(13): 1092 doi: 10.1111/hepr.13223
31
Leke Wiering, Frank Tacke. Treating inflammation to combat non-alcoholic fatty liver diseaseJournal of Endocrinology 2023; 256(1) doi: 10.1530/JOE-22-0194
32
Aleksandra Białczyk, Alicja Rajewska, Roman Junik, Szymon Suwała. The Role of Probiotics in Managing Metabolic-Associated Fatty Liver Disease: An Updated ReviewCurrent Research in Nutrition and Food Science Journal 2024; 12(2): 490 doi: 10.12944/CRNFSJ.12.2.2
33
Qian Song, Xiang Zhang. The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCCBiomedicines 2022; 10(3): 524 doi: 10.3390/biomedicines10030524
34
Penghui Nie, Liehai Hu, Xiaoyan Feng, Hengyi Xu. Gut Microbiota Disorders and Metabolic Syndrome: Tales of a Crosstalk ProcessNutrition Reviews 2024;  doi: 10.1093/nutrit/nuae157
35
Shusong Wu, Ruizhi Hu, Hironobu Nakano, Keyu Chen, Ming Liu, Xi He, Hongfu Zhang, Jianhua He, De-Xing Hou. Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat DietMolecules 2018; 23(12): 3213 doi: 10.3390/molecules23123213
36
A. A. Iakupova, S. R. Abdulkhakov, R. K. Zalyalov, A. G. Safin, R. A. Abdulkhakov. Intestinal Permeability Assays: a ReviewRussian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(1): 20 doi: 10.22416/1382-4376-2021-31-1-20-30
37
Takefumi Kimura, Simran Singh, Naoki Tanaka, Takeji Umemura. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver DiseaseFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.773432
38
Martin J. Page, Douglas B. Kell, Etheresia Pretorius. The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic InflammationChronic Stress 2022; 6 doi: 10.1177/24705470221076390
39
Guido Carpino, Maria Del Ben, Daniele Pastori, Roberto Carnevale, Francesco Baratta, Diletta Overi, Heather Francis, Vincenzo Cardinale, Paolo Onori, Samira Safarikia, Vittoria Cammisotto, Domenico Alvaro, Gianluca Svegliati‐Baroni, Francesco Angelico, Eugenio Gaudio, Francesco Violi. Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLDHepatology 2020; 72(2): 470 doi: 10.1002/hep.31056